Prednisone Active Not Recruiting Phase 2 Trials for Lymphoma, Large B-Cell, Diffuse (DLBCL) Treatment

Active Not RecruitingTreatment2 IdentifierTitleDrugs
NCT03003520A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma
NCT02792491Phase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and Over